Equity Profile

ICLR

ICON Public Limited Company

Health CareLife Sciences Tools & Services$12.9B

May28Thu

Pre-Earnings Brief

UpcomingQ1-2026After Close5:00 PM EDT

Company Snapshot

ICON Public Limited Company (ICLR) operates in the health care sector, specifically in life sciences tools and services. The company plays a crucial role in supporting pharmaceutical and biotechnology companies with clinical development and commercialization of their products.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$2.43

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In Q4 2025, ICON reported an EPS of $2.52, which was slightly above expectations. The stock reacted positively, gaining 4.04% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings this quarter, with a consensus EPS of $2.43 and revenue of $2.0B. The company has a strong track record of beating earnings estimates.

Bull Case

If ICON continues its trend of exceeding EPS estimates, it could see a strong stock price increase, especially given the positive market sentiment around health care.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the current market volatility.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$2.0B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will ICON's EPS exceed the consensus estimate of $2.43?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What guidance will management provide regarding future revenue growth?

Any forward-looking statements about revenue could significantly impact investor sentiment and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate ICON's ability to leverage new contracts and partnerships, which could drive revenue growth beyond current estimates.

Supporting Evidence

ICON has a strong history of beating EPS estimates, with an 86% success rate over the last eight quarters.

The options market suggests a higher-than-average expected move, indicating potential for significant price action.

Recent trends in health care spending could benefit ICON more than analysts are projecting.

Key Risk

If ICON's revenue growth exceeds $2.1B, it could challenge current bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue growth as indicators of ICON's ongoing performance in a competitive health care landscape.

Bull Confirmed If

An EPS of $2.55 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.29 would support the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a move of about 2.09%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around 1.22%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.96%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could impact revenue.
2Management's outlook on market conditions and demand for life sciences services.
3Details on cost management strategies and their impact on margins.
4Insights into competitive pressures and how ICON plans to address them.
5Any commentary on regulatory changes affecting the health care sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$2.43

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In Q4 2025, ICON reported an EPS of $2.52, which was slightly above expectations. The stock reacted positively, gaining 4.04% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings this quarter, with a consensus EPS of $2.43 and revenue of $2.0B. The company has a strong track record of beating earnings estimates.

Bull Case

If ICON continues its trend of exceeding EPS estimates, it could see a strong stock price increase, especially given the positive market sentiment around health care.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the current market volatility.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$2.0B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will ICON's EPS exceed the consensus estimate of $2.43?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What guidance will management provide regarding future revenue growth?

Any forward-looking statements about revenue could significantly impact investor sentiment and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate ICON's ability to leverage new contracts and partnerships, which could drive revenue growth beyond current estimates.

Supporting Evidence

ICON has a strong history of beating EPS estimates, with an 86% success rate over the last eight quarters.

The options market suggests a higher-than-average expected move, indicating potential for significant price action.

Recent trends in health care spending could benefit ICON more than analysts are projecting.

Key Risk

If ICON's revenue growth exceeds $2.1B, it could challenge current bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue growth as indicators of ICON's ongoing performance in a competitive health care landscape.

Bull Confirmed If

An EPS of $2.55 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.29 would support the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a move of about 2.09%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around 1.22%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.96%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could impact revenue.
2Management's outlook on market conditions and demand for life sciences services.
3Details on cost management strategies and their impact on margins.
4Insights into competitive pressures and how ICON plans to address them.
5Any commentary on regulatory changes affecting the health care sector.